Bladder Cancer Trial, Recruiting NCT07204132 Sponsor: Changhai Hospital Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT07204132
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 85 years old (any gender)
  • You have been diagnosed with bladder tumors and confirmed through a biopsy or bladder surgery (TURBT) to have high-risk, early-stage bladder cancer that has not grown into the bladder muscle — this includes tumors at T1 stage, high-grade cancer, or multiple/returning tumors larger than 3 cm
  • You have no more than 5 bladder tumors
  • You want to keep your bladder (rather than have it removed)
  • You are willing to sign a consent form and take part in the full trial

Who may not be able to join:

  • Scans before surgery showed the cancer has spread to nearby organs (such as the ureters, prostate, or rectum), the pelvic or abdominal wall, or to lymph nodes or other parts of the body
  • Scans showed a swollen/blocked kidney, or the cancer was found to be a specific widespread type (carcinoma in situ) or spread throughout the bladder during the diagnostic procedure
  • You have a known allergy to chemotherapy or immunotherapy drugs
  • You have a serious active infection in your blood or body
  • You have a serious problem with blood clotting
  • You have serious heart, brain, lung, liver, or kidney conditions that mean you cannot safely have surgery
  • You currently have or have had another type of cancer
  • You are pregnant or breastfeeding
  • You have a condition such as a narrowed urethra that prevents a bladder camera procedure (cystoscopy)
  • You are currently taking certain medications, including cancer treatments or immune-suppressing drugs
  • You are already taking part in another clinical trial
  • The trial team has another reason they feel makes your participation unsuitable (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86-18930568759

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Changhai Hospital
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
1 September 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Five-year overall survival, OS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov